The Claim
In White individuals, genetically predicted PCSK9 loss of function is associated with a 17% lower risk of peripheral artery disease (PAD), with an odds ratio of 0.83 (95% CI: 0.71–0.97, p = 2.3 × 10⁻⁴), based on data from 227,490 White participants in a multi-ethnic cohort, suggesting that LDL-C lowering via PCSK9 inhibition may reduce PAD risk in this population.
What the research says
Supports is higher
Support is ahead, but a single strong opposing study can change this.
These are independent scores, not a percentage. Higher-grade studies count more, so a single strong opposing study can outweigh several weaker ones.
In White people, having genes that naturally lower PCSK9 are linked to a lower chance of developing leg circulation problems, possibly because of how these genes affect cholesterol.
See the scientific wording
In White individuals, genetically predicted PCSK9 loss of function is associated with a 17% lower risk of peripheral artery disease (PAD), with an odds ratio of 0.83 (95% CI: 0.71–0.97, p = 2.3 × 10⁻⁴), based on data from 227,490 White participants in a multi-ethnic cohort, suggesting that LDL-C lowering via PCSK9 may reduce PAD risk in this population.
What the research says
1 studyThe study looked at genes that naturally lower PCSK9 and found that in White people, this lowers the risk of peripheral artery disease by 17%, just like the claim says.
Score breakdown, mechanism chain, raw evidence, ideal studies needed & 1 supporting studies
Not medical advice. For informational purposes only. Always consult a qualified healthcare professional before making health decisions.